| abstract |
The invention concerns tri-substituted pyrimidines of formula (I), wherein Ra to Re are such as defined in the description, said compounds being used for treating diseases characterized by excessive or abnormal cell proliferation. The invention also concerns the use of said compounds for making a pharmaceutical agent exhibiting said properties, as well as methods for making said compounds. |